| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.0045 | 1 |